Novavax Inc (NVAX): Next-Year EPS Estimate 46.07%
As of 2026-06-04, Novavax Inc (NVAX) has a next-year EPS growth estimate of 46.07%.
On 2026-05-11, analyst consensus for NVAX's next-year EPS growth shifted from 66.08% to 46.07% — a negative change of 20.01 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at -118.29%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 46.07%
- EPS growth this year
- -118.29%
- EPS next quarter (est)
- -$0.40
- Last price
- $10.19
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 46.07% | -118.29% | -$0.40 | $10.19 |
| 2026-06-03 | 46.07% | -118.29% | -$0.40 | $10.20 |
| 2026-06-02 | 46.07% | -118.29% | -$0.40 | $10.21 |
| 2026-06-01 | 46.07% | -118.29% | -$0.40 | $10.51 |
| 2026-05-31 | 46.07% | -118.29% | -$0.40 | $10.97 |
| 2026-05-28 | 46.07% | -118.29% | -$0.40 | $10.32 |
| 2026-05-27 | 46.07% | -118.29% | -$0.40 | $11.09 |
| 2026-05-26 | 46.07% | -118.29% | -$0.40 | $10.46 |
| 2026-05-25 | 46.07% | -118.29% | -$0.40 | $9.21 |
| 2026-05-24 | 46.07% | -118.29% | -$0.40 | $9.21 |
| 2026-05-21 | 46.07% | -118.29% | -$0.40 | $8.98 |
| 2026-05-20 | 46.07% | -118.29% | -$0.40 | $9.27 |
| 2026-05-19 | 46.07% | -118.29% | -$0.40 | $8.90 |
| 2026-05-18 | 46.07% | -118.29% | -$0.40 | $8.93 |
| 2026-05-17 | 46.07% | -118.29% | -$0.40 | $9.06 |
| 2026-05-14 | 46.07% | -118.29% | -$0.40 | $9.35 |
| 2026-05-13 | 46.07% | -118.29% | -$0.40 | $9.35 |
| 2026-05-12 | 46.07% | -118.29% | -$0.40 | $9.62 |
| 2026-05-11 | 46.07% | -118.29% | -$0.40 | $9.50 |
| 2026-05-10 | 66.08% | -120.61% | -$0.40 | $10.11 |
| 2026-05-07 | 58.32% | -118.60% | -$0.37 | $9.23 |
| 2026-05-06 | 65.41% | -116.80% | -$0.33 | $9.36 |
| 2026-05-05 | 38.73% | -115.50% | -$0.23 | $8.10 |
| 2026-05-04 | 38.73% | -115.50% | -$0.23 | $8.03 |
| 2026-05-03 | 38.73% | -115.50% | -$0.23 | $8.04 |
| 2026-04-30 | 38.73% | -115.50% | -$0.23 | $7.93 |
| 2026-04-29 | 38.73% | -115.50% | -$0.23 | $7.97 |
| 2026-04-28 | 38.73% | -115.50% | -$0.23 | $7.92 |
| 2026-04-27 | 38.73% | -115.50% | -$0.23 | $8.07 |
| 2026-04-26 | 38.73% | -115.50% | -$0.23 | $8.22 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Novavax Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Novavax Inc (NVAX) has a next-year EPS growth estimate of 46.07%, based on analyst consensus.
When was the latest EPS estimate revision for NVAX?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 66.08% to 46.07%.
What sector and industry does Novavax Inc belong to?▾
Novavax Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NVAX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Novavax Inc (NVAX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports